glp 1 novo Nordisk, Eli Lilly cut GLP-1 drug costs under Medicare Novo Nordisk is slashing GLP-1

10 Lower diabetes risk : In people with elevated blood sugar, for every 2.2 pounds of weight loss, the risk of developing diabetes drops 16 percent

They dont address the mental load that comes with constantly resisting food

The lawsuit alleges that manufacturers Novo Nordisk and Eli Lilly failed to properly warn patients and healthcare providers about the risks associated with using Ozempic and other GLP-1 drugs

It acts as a metabolic "gas pedal," reducing appetite and serving as a vital marker for mitochondrial health

Dysesthesia, an unpleasant tingling or burning sensation in the skin, affected about 1 in 5 patients on the 12 mg dose and 1 in 13 on the 9 mg dose though Lilly said most cases were mild and rarely caused participants to drop out